![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Aranesp: Uses, Dosage & Side Effects - Drugs.com
2024年3月22日 · Aranesp is used to treat anemia caused by chemotherapy or chronic kidney disease. Aranesp can increase your risk of life-threatening heart or circulation problems, including heart attack or stroke.
Aranesp® (darbepoetin alfa)
Aranesp ® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis. READ MORE
Aranesp (In Albumin) Injection: Uses, Side Effects ... - WebMD
Find patient medical information for Aranesp (in albumin) injection on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Aranesp Syringe - Uses, Side Effects, and More - WebMD
Find patient medical information for Aranesp (in polysorbate) injection on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Aranesp is a man-made form of the protein human erythropoietin that is given to reduce or avoid the need for red blood cell transfusions. Aranesp stimulates your bone marrow to make...
Aranesp (Darbepoetin Alfa): Side Effects, Uses, Dosage ... - RxList
2024年10月17日 · Aranesp (darbepoetin alfa) is an erythropoiesis-stimulating agent, or ESA, used to treat anemia (a lack of red blood cells in the body) in people with long-term serious kidney disease (chronic renal failure) and people receiving chemotherapy for some types of cancer. What Are Side Effects of Aranesp?
Aranesp: Package Insert / Prescribing Information - Drugs.com
Aranesp is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Aranesp works like the human protein called erythropoietin to help your body make more RBCs. Aranesp is used to reduce or avoid the need for RBC transfusions. Aranesp may be used to treat anemia if it is caused by:
Aranesp® is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. Aranesp® has not been shown to improve quality of life, fatigue, or patient well-being.
Use the lowest Aranesp dose sufficient to reduce the need for red blood cell (RBC) transfusions [see Warnings and Precautions (5.1)].
used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Aranesp. works like the human protein called erythropoietin to help your b. up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happ.